Clinical studies have documented reductions in hunger scores, increased fullness ratings, and decreased caloric intake with cagrilintide treatment
This feature helps reduce the cognitive load when appetite suppression already makes eating feel like a chore
They stress that there is little evidence of benefit for healthy people and that the treatments can be very expensive
The 8-week recommendation provides additional safety margin beyond complete elimination
The semaglutide weight management drug market continued to rely on injectable products because prescribers viewed subcutaneous delivery as more predictable in bioavailability and dose response, which is especially important during escalation, monitoring, and long-term persistence management
GLP-1 receptor agonists, originally developed for type 2 diabetes management, had become blockbuster weight loss drugs